COTL1 protein involved in maintaining homeostasis of hematopoietic stem cell, and use thereof
A COTL1 gene or protein maintains and regulates the homeostasis of hematopoietic stem cells. A method of diagnosis and treatment of blood-related disease caused either by abnormalities in the homeostasis of hematopoietic stem cells, which result from a mutation in the COTL1 gene or a decrease in the expression of the COTL1 protein, or by an imbalance between the differentiation or proliferation and damage or death of hematopoietic stem cells, or by abnormalities in mitochondrial homeostasis are disclosed. The COTL1 gene or protein plays an important role in regulating mitochondrial morphology, and when it is knocked down, the number of hematopoietic stem cells decreases.
1. A method for treating a blood-related disease in a subject in need thereof, the method comprising administering to the subject an effective amount of an inhibitor of expression of COTL1 protein,
wherein the blood-related disease is a leukemia caused by an increase in abnormal proliferation of hematopoietic stem cells, and the treating comprises a decrease in a number of hematopoietic stem cells compared to prior to the administering,
wherein the administering reduces a number of hematopoietic stem cells, and
wherein the inhibitor is any one selected from the group consisting of an antisense nucleotide, a small interfering RNA (siRNA), and a short hairpin RNA (shRNA), which each bind complementarily to the mRNA of the COTL1 gene, and a combination thereof,
wherein the inhibitor is a morpholino oligonucleotide comprising the sequence of SEQ ID: 5.
2. The method of claim 1 , wherein the blood-related disease is selected from the group consisting of acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia.
3. The method of claim 1 , wherein the blood-related disease is caused by i) abnormalities in the homeostasis of hematopoietic stem cells, ii) an imbalance between the differentiation or proliferation and damage or death of hematopoietic stem cells, or iii) abnormalities in mitochondrial homeostasis.